NO163514C - Fremgangsmaate for fremstilling av blodplasma. - Google Patents
Fremgangsmaate for fremstilling av blodplasma.Info
- Publication number
- NO163514C NO163514C NO831304A NO831304A NO163514C NO 163514 C NO163514 C NO 163514C NO 831304 A NO831304 A NO 831304A NO 831304 A NO831304 A NO 831304A NO 163514 C NO163514 C NO 163514C
- Authority
- NO
- Norway
- Prior art keywords
- factor viii
- plasma
- blood plasma
- procedure
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0035—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Lubricants (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/368,250 US4481189A (en) | 1982-04-14 | 1982-04-14 | Process for preparing sterilized plasma and plasma derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NO831304L NO831304L (no) | 1983-10-17 |
NO163514B NO163514B (no) | 1990-03-05 |
NO163514C true NO163514C (no) | 1990-06-13 |
Family
ID=23450479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO831304A NO163514C (no) | 1982-04-14 | 1983-04-13 | Fremgangsmaate for fremstilling av blodplasma. |
Country Status (13)
Country | Link |
---|---|
US (1) | US4481189A (fr) |
EP (1) | EP0099445B2 (fr) |
JP (1) | JPH0660105B2 (fr) |
AT (1) | ATE58835T1 (fr) |
AU (1) | AU561900B2 (fr) |
CA (1) | CA1207229A (fr) |
DE (1) | DE3382042D1 (fr) |
DK (1) | DK164537C (fr) |
ES (1) | ES521431A0 (fr) |
FI (1) | FI80211C (fr) |
NO (1) | NO163514C (fr) |
NZ (1) | NZ203878A (fr) |
ZA (1) | ZA832239B (fr) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581231A (en) * | 1982-06-10 | 1986-04-08 | The United States Of America As Represented By The Secretary Of Health And Human Services | Inactivation of viruses containing essential lipids |
CA1213827A (fr) * | 1983-04-29 | 1986-11-12 | Ricardo H. Landaburu | Procede de pasteurisation de la fibronectine |
US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
US4615886A (en) * | 1983-08-31 | 1986-10-07 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus |
AT389815B (de) * | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
EP0172716A1 (fr) * | 1984-08-14 | 1986-02-26 | Shiley Incorporated | Inhibition de la calcification de tissus implantables à l'aide de bétaines tensio-actives |
JPS61103836A (ja) * | 1984-10-24 | 1986-05-22 | Green Cross Corp:The | フイブロネクチン製剤 |
US4613501A (en) * | 1984-12-21 | 1986-09-23 | New York Blood Center, Inc. | Inactivation of viruses in labile blood derivatives |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US4649192A (en) * | 1985-05-30 | 1987-03-10 | Smith Kline-Rit | Method for the isolation and purification of hepatitis B surface antigen using polysorbate |
US5185371A (en) * | 1986-03-10 | 1993-02-09 | University Of Southern California | Method for disinfecting red blood cells |
US5281392A (en) * | 1986-03-10 | 1994-01-25 | Rubinstein Alan I | Method for disinfecting red blood cells, blood products, and corneas |
US5211912A (en) * | 1986-08-01 | 1993-05-18 | University Of Southern California | Method for disinfecting red blood cells, blood products, and corneas |
US4971760A (en) * | 1986-03-10 | 1990-11-20 | University Of Southern California | Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae |
AT390374B (de) * | 1986-03-18 | 1990-04-25 | Schwab & Co Gmbh | Verfahren zum pasteurisieren von plasmaprotein und plasmaproteinfraktionen |
US4789545A (en) * | 1986-03-31 | 1988-12-06 | New York Blood Center, Inc. | Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
US4749783A (en) * | 1986-07-11 | 1988-06-07 | Miles Laboratories, Inc. | Viral inactivation and purification of active proteins |
US4944920A (en) * | 1986-08-01 | 1990-07-31 | University Of Southern California | Novel method to treat blood |
JPH02500022A (ja) * | 1986-08-01 | 1990-01-11 | ルービンスタイン,アラン,アイ | 新規な血液処理法 |
DE3704550A1 (de) * | 1987-02-13 | 1988-08-25 | Behringwerke Ag | Verfahren zur inaktivierung huellhaltiger viren in mittels einer zelle in vitro hergestellten protein-praeparationen |
CA1339946C (fr) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Methode d'ultrapurification pour les polypeptides |
US4869826A (en) * | 1987-09-01 | 1989-09-26 | Process Biotechnology, Inc. | Cellular adsorbents for removal of viral contaminants from blood and complex protein solutions |
DE3733181C1 (de) * | 1987-10-01 | 1989-01-19 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
DE3805459A1 (de) * | 1988-02-22 | 1989-08-31 | Biotest Pharma Gmbh | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
DE3826792C1 (fr) * | 1988-08-06 | 1989-07-06 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
US5094960A (en) | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
US4939176A (en) * | 1988-12-20 | 1990-07-03 | Miles Inc. | Viral inactivation process |
US5026686A (en) * | 1989-02-01 | 1991-06-25 | Washington University | Antiviral peptides |
US5202246A (en) * | 1989-08-16 | 1993-04-13 | Armour Pharmaceutical Company | Treatment of immobilized matrices for preparation of pharmaceutical and biological products with anti-microbial agents to remove pyrogen-producing organisms and pyrogens |
GB9110808D0 (en) * | 1991-05-17 | 1991-07-10 | Retroscreen Ltd | Aids vaccine and method for its production |
AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
DE4125625C2 (de) * | 1991-08-02 | 1999-12-02 | Octapharma Ag Glarus | Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen |
AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
KR100303872B1 (ko) * | 1992-10-02 | 2001-11-22 | 크리스터 발스트룀, 프레드릭 베르그, 하랄트 알름 | 응고인자ⅷ제형을포함하는조성물,이것의제조방법및안정화제로서의계면활성제의사용방법 |
AU6653094A (en) * | 1992-12-16 | 1994-07-04 | Immuno Aktiengesellschaft | Process for preparing a virus-safe biological composition |
SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
WO1995000631A1 (fr) * | 1993-06-23 | 1995-01-05 | New York Blood Center, Inc. | Systeme pour inactiver les virus du sang |
CA2168470C (fr) | 1993-07-30 | 2008-03-18 | Bill Elliot Cham | Systeme de degraissage du plasma |
HRP940645A2 (en) * | 1993-10-06 | 1996-12-31 | Immuno Ag | Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
FR2716111B1 (fr) * | 1994-02-11 | 1996-11-08 | Cogia | Procédé de préparation d'une composition cosmétique ou alimentaire apte à être conservée, dispositif et composition de longue conservation. |
US5486293A (en) * | 1994-03-21 | 1996-01-23 | Hemasure, Inc. | Removal of small exogenous molecules from biological fluids |
JP4211894B2 (ja) † | 1994-07-14 | 2009-01-21 | シーエーエフ‐ディーシーエフ シーブイビーエー‐エスシーアールエル | 血漿から得られるフィブリノーゲン濃縮物及びその製法 |
AUPN030794A0 (en) | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
FI952196A0 (fi) * | 1995-05-08 | 1995-05-08 | Suomen Punainen Risti Veripalv | Framstaellning av immunoglobulin |
AU5929896A (en) * | 1995-05-26 | 1996-12-11 | Sadeque S. Naficy | Apparatuses and methods for treatment of blood |
DE19528221C2 (de) * | 1995-08-01 | 1998-10-22 | Blutspendedienst Der Drk Lande | Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma |
US20040053208A1 (en) * | 1995-08-29 | 2004-03-18 | V. I. TECHNOLOGIES, Inc. | Methods to selectively inactivate parasites in biological compositions |
US6369048B1 (en) | 1998-01-12 | 2002-04-09 | V.I. Technologies, Inc. | Methods and compositions for inactivating viruses |
EP1154796B1 (fr) * | 1999-02-22 | 2007-06-20 | University of Connecticut | Nouvelles formulations de facteur viii sans albumine |
US6436344B1 (en) | 1999-11-02 | 2002-08-20 | American National Red Cross | Method of inactivating pathogens |
JP5080713B2 (ja) * | 1999-12-20 | 2012-11-21 | 田辺三菱製薬株式会社 | 多孔性膜処理によるウイルスの除去された血漿蛋白組成物の製造方法、ウイルスの除去された血漿蛋白組成物およびウイルス除去方法 |
US8529884B2 (en) * | 1999-12-22 | 2013-09-10 | The Trustees Of The University Of Pennsylvania | Cosmid DNA constructs and methods of making and using same |
AUPQ486699A0 (en) * | 1999-12-23 | 2000-02-03 | Aruba International Pty Ltd | A method of treating infectious diseases |
US7407663B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified immunodeficiency virus particles |
US7407662B2 (en) * | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified viral particles with immunogenic properties and reduced lipid content |
US7439052B2 (en) | 2000-06-29 | 2008-10-21 | Lipid Sciences | Method of making modified immunodeficiency virus particles |
US20090017069A1 (en) | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
US6635679B2 (en) * | 2001-05-14 | 2003-10-21 | Akzo Nobel N.V. | Methods and compositions for inactivating viruses |
US20060060520A1 (en) | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
US7033500B2 (en) | 2001-06-25 | 2006-04-25 | Lipid Sciences, Inc. | Systems and methods using multiple solvents for the removal of lipids from fluids |
US6991727B2 (en) | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
US6893639B2 (en) * | 2001-10-19 | 2005-05-17 | Hemacare Corporation | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
US20030133829A1 (en) * | 2001-12-21 | 2003-07-17 | Baxter Healthcare Corporation | Process for inactivating pathogens in a biological material |
WO2004075931A2 (fr) | 2003-02-27 | 2004-09-10 | Baxter International Inc. | Methode d'inactivation certifiable de pathogenes dans un fluide biologique, par irradiation |
US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
PT2368565E (pt) | 2003-07-03 | 2015-10-19 | Hdl Therapeutics Inc | Enriquecimento de lipoproteínas pré-beta de alta densidade |
US6881573B2 (en) * | 2003-09-12 | 2005-04-19 | Allan L. Louderback | Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses |
EP3127916A1 (fr) | 2004-06-07 | 2017-02-08 | Therapure Biopharma Inc. | Isolation de protéines sériques ou plasmatiques |
US7993580B2 (en) * | 2004-08-24 | 2011-08-09 | Baxter International Inc. | Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors |
EP1685852A1 (fr) | 2005-02-01 | 2006-08-02 | Fondation pour la Recherche Diagnostique | Set des sacs jetable pour l'inactivation virale des fluides biologiques |
AU2007264735B2 (en) * | 2006-06-26 | 2012-11-08 | Omrix Biopharmaceuticals Inc. | Virus removal by nanofiltration |
US9956272B2 (en) | 2007-05-30 | 2018-05-01 | Bio Products Laboratory Limited | Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same |
GB0710321D0 (en) * | 2007-05-30 | 2007-07-11 | Nhs Blood & Transplant | Method |
US20110033554A1 (en) * | 2008-03-28 | 2011-02-10 | Research Foundation For Medical Devices | Method of Viral Inactivation of Biological Fluids |
BRPI0921429B1 (pt) | 2008-11-07 | 2022-07-12 | Takeda Pharmaceutical Company Limited | Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável |
EP2399613A1 (fr) | 2010-06-22 | 2011-12-28 | Research Foundation For Medical Devices | Fractionnement plasmatique par l'acide caprylique |
CN106138851A (zh) * | 2016-09-08 | 2016-11-23 | 四川聚豪生物科技有限公司 | 一种可有效治疗乙肝的汤剂药物及其制备方法 |
EP3714039A4 (fr) | 2017-11-22 | 2021-07-28 | HDL Therapeutics, Inc. | Systèmes et procédés pour amorcer des circuits fluides d'un système de traitement de plasma |
WO2019133358A2 (fr) | 2017-12-28 | 2019-07-04 | Hdl Therapeutics, Inc. | Procédés de conservation et d'administration de pré-bêta lipoprotéines de haute densité extraites à partir de plasma humain |
US20200224164A1 (en) | 2018-11-30 | 2020-07-16 | Cellphire, Inc. | Platelets as delivery agents |
WO2020227149A1 (fr) | 2019-05-03 | 2020-11-12 | Cellphire, Inc. | Matériaux et procédés de production de produits sanguins |
WO2021046409A1 (fr) * | 2019-09-05 | 2021-03-11 | Cellphire, Inc. | Matériaux et procédés pour préparations de plasma sanguin |
WO2021158622A1 (fr) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Plaquettes chargées antifibrinolytiques |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105650A (en) * | 1975-04-11 | 1978-08-08 | Edward Shanbrom, Inc. | Method of preserving blood plasma i |
GB1507215A (en) * | 1975-08-19 | 1978-04-12 | Green Cross Corp | Processes for producing immunoregulatory preparations |
US4057628A (en) * | 1976-04-19 | 1977-11-08 | William L. Wilson | Removal of hepatitis associated antigen from plasma |
US4222934A (en) * | 1979-04-12 | 1980-09-16 | American National Red Cross | Preparation of albumin using ethanol |
DE3176491D1 (en) * | 1980-03-05 | 1987-11-26 | Miles Lab | Pasteurized therapeutically active protein compositions |
US4305871A (en) * | 1980-09-02 | 1981-12-15 | Edward Shanbrom | Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating |
DE3033932C2 (de) * | 1980-09-10 | 1984-05-24 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten |
DE3173208D1 (en) * | 1980-10-06 | 1986-01-23 | Edward Shanbrom | Method of reducing undesirable activities of biological and pharmaceutical products |
US4314997A (en) * | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
US4315919A (en) * | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
-
1982
- 1982-04-14 US US06/368,250 patent/US4481189A/en not_active Expired - Lifetime
-
1983
- 1983-03-26 EP EP83103049A patent/EP0099445B2/fr not_active Expired - Lifetime
- 1983-03-26 AT AT83103049T patent/ATE58835T1/de not_active IP Right Cessation
- 1983-03-26 DE DE8383103049T patent/DE3382042D1/de not_active Expired - Lifetime
- 1983-03-29 ZA ZA832239A patent/ZA832239B/xx unknown
- 1983-04-05 FI FI831146A patent/FI80211C/fi not_active IP Right Cessation
- 1983-04-13 AU AU13462/83A patent/AU561900B2/en not_active Ceased
- 1983-04-13 NZ NZ203878A patent/NZ203878A/en unknown
- 1983-04-13 ES ES521431A patent/ES521431A0/es active Granted
- 1983-04-13 NO NO831304A patent/NO163514C/no not_active IP Right Cessation
- 1983-04-13 DK DK162983A patent/DK164537C/da not_active IP Right Cessation
- 1983-04-14 CA CA000425864A patent/CA1207229A/fr not_active Expired
- 1983-04-14 JP JP58064638A patent/JPH0660105B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0099445B2 (fr) | 1998-07-08 |
EP0099445A3 (en) | 1985-01-16 |
US4481189A (en) | 1984-11-06 |
ZA832239B (en) | 1984-11-28 |
DK162983D0 (da) | 1983-04-13 |
FI80211C (fi) | 1990-05-10 |
JPH0660105B2 (ja) | 1994-08-10 |
FI831146L (fi) | 1983-10-15 |
JPS58222023A (ja) | 1983-12-23 |
ATE58835T1 (de) | 1990-12-15 |
EP0099445B1 (fr) | 1990-12-05 |
NZ203878A (en) | 1986-02-21 |
DE3382042D1 (de) | 1991-01-17 |
EP0099445A2 (fr) | 1984-02-01 |
NO163514B (no) | 1990-03-05 |
AU1346283A (en) | 1983-10-20 |
FI831146A0 (fi) | 1983-04-05 |
AU561900B2 (en) | 1987-05-21 |
CA1207229A (fr) | 1986-07-08 |
ES8403722A1 (es) | 1984-04-01 |
ES521431A0 (es) | 1984-04-01 |
DK164537B (da) | 1992-07-13 |
DK162983A (da) | 1983-10-15 |
NO831304L (no) | 1983-10-17 |
FI80211B (fi) | 1990-01-31 |
DK164537C (da) | 1992-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO163514C (no) | Fremgangsmaate for fremstilling av blodplasma. | |
US4613501A (en) | Inactivation of viruses in labile blood derivatives | |
Doms et al. | Quaternary structure of influenza virus hemagglutinin after acid treatment | |
EP0131740B2 (fr) | Dérivés de protéines non dénaturés biologiquement actifs et dépourvus de virus | |
US5186945A (en) | Blood plasma antiviral process and composition | |
CA1223203A (fr) | Composes de proteines exempts d'agents infectieux | |
ES8705764A1 (es) | Procedimiento fotodinamico de inactivacion de virus | |
HU9201986D0 (en) | A blood preparation inactivated to viruses | |
ATE178490T1 (de) | Cytopathische viren zur therapie und prophylaxe der neoplasie | |
ATE335810T1 (de) | Verfahren zur inaktivierung von lipidumhüllten viren | |
AU3216695A (en) | Lipid analogs for treating viral infections | |
ES8608577A1 (es) | Un metodo para inactivar virus que contienen lipidos esen- ciales en un vehiculo proteinico seco | |
ES2123048T3 (es) | Analogos de nucleosidos antiviricos. | |
DE68923169D1 (de) | Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen. | |
ATE115863T1 (de) | Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen. | |
FI881123A (fi) | Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar. | |
Gerety | Prevention of transmission of virus infections by blood transfusions and removal of virus infectivity from clotting factor concentrates | |
DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
Horowitz | Virus sterilization of plasma proteins by treatment with solvent/detergent mixtures—a summary | |
Coursaget et al. | Clinical Research: Incidence and Chronicity of Non-A, Non-B Hepatitis in Burn Patients | |
長尾大 et al. | Follow-up Survey after Administration of Hemofil M to Previously Untreated Patients (PUPs) with Hemophilia A. | |
Stephan et al. | INACTIVATION OF HEPATITIS VIRUSES AND HIV IN PLASMA AND PLASMA DERIVATIVES BY COMBINED TREATMENTWITH β-PR0PI0LACT0NE/UV-IRRADIATION | |
Werner et al. | Hepatitis Prophylaxis | |
Um et al. | Infectious Disease Markers among Directed and Volunteer Blood Donors in Korea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |
Free format text: EXPIRED IN APRIL 2003 |